C12N 2760/20245
Special targeting system for viral vectors
C12N2760/20245 (Special targeting system for viral vectors) appears on 18 US grants and 34 published applications in this corpus.
Search patents in C12N- Granted patents
- 18
- Published applications
- 34
- Assignees
- 23
- Inventors
- 59
- Latest grant
- 28 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 3 |
| 2018 | 1 | 0 |
| 2019 | 2 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 1 | 3 |
| 2024 | 3 | 11 |
| 2025 | 8 | 4 |
| 2026 | 0 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant rhabdovirus encoding for CCL2128 Oct 2025US 12,453,749 B2Boehringer Ingelheim International GmbH
- Compositions and methods for treatment of cytomegalovirus23 Sep 2025US 12,421,283 B2Variation Biotechnologies Inc.
- Mutated glycoprotein of vesicular stomatitis virus9 Sep 2025US 12,410,215 B2Centre National de la Recherche Scientifique (CNRS)
- Mutated glycoprotein of vesicular stomatitis virus9 Sep 2025US 12,410,216 B2Centre National de la Recherche Scientifique (CNRS)
- Mutated glycoprotein of vesicular stomatitis virus13 May 2025US 12,297,237 B2Centre National de la Recherche Scientifique (CNRS)
- Arrdc1-mediated microvesicle-based delivery of therapeutic agents to cells of the peripheral nervous system27 Aug 2026US 2026/0248957 A1Turn Biotechnologies, Inc.
- Mutant vsvg and targeting vector13 Aug 2026US 2026/0234198 A1Shenzhen Genocury Biotech Co., Ltd.
- Targeting vector, preparation method therefor and use thereof21 May 2026US 2026/0137811 A1Shenzhen Genocury Biotech Co., Ltd.
- Recombinant rhabdovirus encoding for a gasdermin30 Apr 2026US 2026/0117200 A1Boehringer Ingelheim International GmbH
- Mutated Glycoprotein of Vesicular Stomatitis Virus19 Mar 2026US 2026/0078150 A1Centre National de la Recherche Scientifique (CNRS)
Most cited
By later US patents
- Compositions and methods for treatment of cytomegalovirus20US 9,777,043 B2Variation Biotechnologies Inc. · 2017
- Mutated glycoprotein of vesicular stomatitis virus10US 12,030,915 B2Centre National de la Recherche Scientifique (CNRS) · 2024
- Mutated glycoprotein of vesicular stomatitis virus3US 12,091,434 B2Centre National de la Recherche Scientifique (CNRS) · 2024
- Mutated glycoprotein of vesicular stomatitis virus3US 12,264,180 B2Centre National de la Recherche Scientifique (CNRS) · 2025
- Mutated glycoprotein of vesicular stomatitis virus3US 12,269,848 B2Centre National de la Recherche Scientifique (CNRS) · 2025